Global Companion Diagnostics Market is expected to grow at a healthy rate of ~13% by 2027 :…
<!-- Name:DistributionId Value:1000805321 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value:5500 -->…
Browsing Tag
companion diagnostics
Companion Diagnostics Market to Expand at a CAGR of 9% during Forecast Period: TMR Study
<!-- Name:DistributionId Value:8812731 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value: -->…
Companion Diagnostics Market Sales to Top US$ 4,786 Mn in Revenues by 2032, At a CAGR of 3.1%
<!-- Name:DistributionId Value:8804737 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value:2790 -->…
Companion Diagnostics Market Size to Hit USD 5,471.68 Million by 2030 at 11.90% CAGR – Report by…
<!-- Name:DistributionId Value:8752636 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value: -->…
With 11% CAGR, Companion Diagnostics Market Size to Surpass USD 15.91 Billion by 2029
<!-- Name:DistributionId Value:8746776 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value:5557 -->…
Companion Diagnostics Market Size Worth USD 15.91 billion by 2029 | Report by Fortune Business…
Pune, India, Jan. 10, 2023 (GLOBE NEWSWIRE) -- The global companion diagnostics market size was valued at USD 6.80 billion in 2021. The market is projected to grow from USD 7.67 billion in 2022 to USD 15.91 billion by 2029, exhibiting a…
Akoya Biosciences to Partner with Acrivon Therapeutics for the Clinical Development of Acrivon’s…
The OncoSignature® test developed based on Acrivon’s AP3 platform is a first-of-its-kind spatial signature assay to identify patients most likely to respond to ACR-368, an advanced Phase 2 targeted oncology agent for solid cancers The…